Investing

REGENXBIO’s gene therapy with CT domain shows improved muscle function in study

ROCKVILLE, Md. - REGENXBIO Inc. (NASDAQ:RGNX), a biotechnology company whose stock has gained over 22% in the past six months and is currently considered undervalued according to InvestingPro analysis ...